Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.
DyNAmo qPCR Kits

Site Tools

  • AAAS
  • Subscribe
  • Feedback

Site Search

Search Advanced

Science 3 July 1998:
Vol. 281. no. 5373, pp. 22 - 23
DOI: 10.1126/science.281.5373.22
Prev | Table of Contents | Next

News of the Week

MEDICAL ETHICS:
No Consensus on Rules for AIDS Vaccine Trials

Jon Cohen

GENEVA, SWITZERLAND--A meeting held here last week to try to set ethical ground rules for AIDS vaccine trials in poor countries almost reached boiling point when the participants grappled with a key question: If a vaccine is tested in a country that cannot afford anti-HIV drugs and volunteers become infected during the trial, should they be given state-of-the-art treatment? The answer could determine the ethical, financial, and scientific viability of AIDS vaccine tests. But for the 85 AIDS vaccine developers, ethicists, public health officials, lawyers, and activists from more than two dozen countries who tried to answer it, consensus proved elusive.

Read the Full Text

ADVERTISEMENT
Click Me!

ADVERTISEMENT
Click Me!

To Advertise     Find Products

Science. ISSN 0036-8075 (print), 1095-9203 (online)